Status:
COMPLETED
Fetal Alcohol Spectrum Disorder-Is This a Ciliopathy?
Lead Sponsor:
University of Alberta
Conditions:
Fetal Alcohol Spectrum Disorder
Eligibility:
All Genders
5-16 years
Phase:
NA
Brief Summary
Urine sample and exhaled Nitric Oxide will analyzed and compared between children diagnosed with Fetal Alcohol Spectrum Disorder and healthy control. Pilot study- 5 children in each group
Detailed Description
Background: The term "fetal alcohol spectrum disorder" (FASD) describes a broad spectrum of neurodevelopmental presentations resulting from alcohol exposure in utero. The prevalence has been estimated...
Eligibility Criteria
Inclusion
- Children ages 5-16
- Diagnosis of FASD
Exclusion
- Sinopulmonary anomaly
- Cardiac anomaly
- Asthma
- Previously known Genetic condition
- Previously known Metabolic condition
- Polypharmacy
Key Trial Info
Start Date :
September 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 23 2020
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03802708
Start Date
September 1 2018
End Date
March 23 2020
Last Update
March 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Glenrose rehabilitation hospital
Edmonton, Alberta, Canada, T5G 0B7